VJOncology is committed to improving our service to you

ASCO 2020 | Myelopreservation and reduced use of supportive care with trilaciclib in patients with SCLC

VJOncology is committed to improving our service to you

Jared Weiss

Jared Weiss, MD, of UNC Lineberger, Chapel Hill, NC, outlines studies investigating trilaciclib, a CDK4/6 inhibitor, for myelopreservation and reduced use of supportive care in small cell lung cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter